Pre-operative IRX-2 in Early Stage Breast Cancer (ESBC)
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Neoplasm|Breast Neoplasm, Male|Triple Negative Breast Cancer
Interventions: DRUG: Cyclophosphamide|DRUG: Indomethacin|DRUG: Omeprazole|DIETARY_SUPPLEMENT: Multivitamin
Sponsor: Providence Health & Services
Collaborators: Brooklyn ImmunoTherapeutics, LLC